Early termination of drug trials

BMJ. 2007 Feb 17;334(7589):326. doi: 10.1136/bmj.39113.534919.80.

Abstract

What are the ramifications for drug companies and drug safety monitoring boards?

Publication types

  • Editorial

MeSH terms

  • Adverse Drug Reaction Reporting Systems
  • Cholesterol, HDL / blood
  • Drug Industry
  • Quinolines / therapeutic use*
  • Randomized Controlled Trials as Topic / methods*
  • Randomized Controlled Trials as Topic / mortality

Substances

  • Cholesterol, HDL
  • Quinolines
  • torcetrapib